Cargando…
In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals
INTRODUCTION: Helicobacter pylori is Gram-negative helical bacteria that inhibit stomach mucosal lining and establish infection. Urease enzyme was confirmed to be pivotal target in which its suppression will prompt bacteria treatment and eradication. METHODS: Series of naturally bioactive compounds...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728063/ https://www.ncbi.nlm.nih.gov/pubmed/36506725 http://dx.doi.org/10.4103/jpbs.jpbs_850_21 |
_version_ | 1784845164790939648 |
---|---|
author | Al Tawalbeh, Deniz Aburjai, Talal Al Balas, Qosay Al Samydai, Ali |
author_facet | Al Tawalbeh, Deniz Aburjai, Talal Al Balas, Qosay Al Samydai, Ali |
author_sort | Al Tawalbeh, Deniz |
collection | PubMed |
description | INTRODUCTION: Helicobacter pylori is Gram-negative helical bacteria that inhibit stomach mucosal lining and establish infection. Urease enzyme was confirmed to be pivotal target in which its suppression will prompt bacteria treatment and eradication. METHODS: Series of naturally bioactive compounds were selected based on ethnobotanical and molecular modeling techniques with potential urease inhibitory effect. The selected phytochemical compounds were in-silico and in-vitro assayed against urease enzyme, minimal inhibitory concentrations (MIC) and a synergistic effect was studied and cultured specifically for H. pylori. RESULTS: Terpineol was considered as the most active compound with an IC(50) of 1.443 μg/ml (R(2) = 0.9374). The synergistic effect of terpineol and metronidazole indicated a possible additive effect (fractional inhibitory concentration result is 0.78) with improvement of MIC results for both terpineol and metronidazole. CONCLUSION: This study suggests that terpineol is best to be considered as a lead compound for H. pylori infection treatment and could be a potent inhibitor when combined with metronidazole targeting urease enzyme. |
format | Online Article Text |
id | pubmed-9728063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-97280632022-12-08 In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals Al Tawalbeh, Deniz Aburjai, Talal Al Balas, Qosay Al Samydai, Ali J Pharm Bioallied Sci Original Article INTRODUCTION: Helicobacter pylori is Gram-negative helical bacteria that inhibit stomach mucosal lining and establish infection. Urease enzyme was confirmed to be pivotal target in which its suppression will prompt bacteria treatment and eradication. METHODS: Series of naturally bioactive compounds were selected based on ethnobotanical and molecular modeling techniques with potential urease inhibitory effect. The selected phytochemical compounds were in-silico and in-vitro assayed against urease enzyme, minimal inhibitory concentrations (MIC) and a synergistic effect was studied and cultured specifically for H. pylori. RESULTS: Terpineol was considered as the most active compound with an IC(50) of 1.443 μg/ml (R(2) = 0.9374). The synergistic effect of terpineol and metronidazole indicated a possible additive effect (fractional inhibitory concentration result is 0.78) with improvement of MIC results for both terpineol and metronidazole. CONCLUSION: This study suggests that terpineol is best to be considered as a lead compound for H. pylori infection treatment and could be a potent inhibitor when combined with metronidazole targeting urease enzyme. Wolters Kluwer - Medknow 2022 2022-09-19 /pmc/articles/PMC9728063/ /pubmed/36506725 http://dx.doi.org/10.4103/jpbs.jpbs_850_21 Text en Copyright: © 2022 Journal of Pharmacy and Bioallied Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Al Tawalbeh, Deniz Aburjai, Talal Al Balas, Qosay Al Samydai, Ali In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals |
title | In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals |
title_full | In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals |
title_fullStr | In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals |
title_full_unstemmed | In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals |
title_short | In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals |
title_sort | in silico and in vitro investigation of anti helicobacter activity of selected phytochemicals |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728063/ https://www.ncbi.nlm.nih.gov/pubmed/36506725 http://dx.doi.org/10.4103/jpbs.jpbs_850_21 |
work_keys_str_mv | AT altawalbehdeniz insilicoandinvitroinvestigationofantihelicobacteractivityofselectedphytochemicals AT aburjaitalal insilicoandinvitroinvestigationofantihelicobacteractivityofselectedphytochemicals AT albalasqosay insilicoandinvitroinvestigationofantihelicobacteractivityofselectedphytochemicals AT alsamydaiali insilicoandinvitroinvestigationofantihelicobacteractivityofselectedphytochemicals |